Profit Attributable to Shareholders Increased by 23.9% to a Record High of HK$250.6 Million; Total Dividend Up 18.4% to HK4.5…
Browsing: HealthCare
TransCanna Holdings Inc. (CSE: TCAN) (OTC PINK: TCNAF) (FSE: TH8) (“TransCanna” or the “Company”) has hired Alan R. Applonie as…
Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) (“SeD”) wishes to announce today that its U.S. biomedical subsidiary, Global BioLife…
TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (OTC PINK: TCNAF) (“TransCanna” or the “Company”) is pleased to announce that it…
Proteomics International meeting with US tier 1 national diagnostic groups to expand global roll-out of PromarkerD including EU and Mexico…
PromarkerD world’s leading diagnostic test for diabetic kidney disease says Frost & Sullivan industry report ‘Biomarkers Enabling Diabetes and Obesity…
아시아태평양 전문 임상시험수탁기관(CRO) 노보텍(Novotech)이 선도적인 분석 업체 프로스트&설리번(Frost & Sullivan)이 수여하는 올해의 아시아태평양 CRO 상을 받는 영예를 다시 한번 안았다.…
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost…
Revenue Up 33.4% to RMB6,208 Million Underlying Profit* Climbs 22.4% to RMB976 Million Sino Biopharmaceutical Limited (“Sino Biopharmaceutical” or the…
Offer Price Set Between HK$1.50 to HK$1.95 per Share, To Raise Gross Proceeds Up to HK$1,528 Million A Leading Biopharmaceutical…
More than 12,000 buyers visit 2019 fair, up 8% on last year The 10th HKTDC Hong Kong International Medical and…
Organised by the Hong Kong Trade Development Council (HKTDC) and co-organised by the Hong Kong Medical and Healthcare Device Industries…
– Includes 10 leading oncology/translational medicine and drug development experts to support clinical strategy for TR009 and TRIGR’s immuno-modulatory bispecific…
Captiva Verde Land Corp. (CSE: PWR) (the “Company”), is pleased to announce that Captiva Verde has acquired Solargram Farms Corporation…
Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene…
Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Group”; Stock Code: 2633), a leading company engaging in the research, development,…
Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has appointed Haywood…
Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce today the execution of a…
Expects to Record Over 20% Increase in Profit Attributable to Shareholders Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”;…
Vancouver, BC – (ACN Newswire) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) applied for a permanent manufacturing, distribution…